Insigneo Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Insigneo Advisory Services's XBI Position: Q2 2026 in Review
Insigneo Advisory Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q2 2026, buying an estimated $55.4K and bringing the position to 2,518 shares worth $398K. The position accounts for 0.01% of the portfolio, ranked #543.
Insigneo Advisory Services first reported a position in XBI in Q4 2022 and has held it in 10 quarters since. The position peaked at $552K in Q1 2024. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Insigneo Advisory Services held 2,518 shares of State Street SPDR S&P Biotech ETF worth $398K as of Q2 2026.
- Insigneo Advisory Services bought 410 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $55.4K.
- State Street SPDR S&P Biotech ETF made up 0.01% of Insigneo Advisory Services's portfolio in Q2 2026, its #543 holding.
- Insigneo Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 10 quarters since.
- Insigneo Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $552K in Q1 2024.
- 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Insigneo Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.